Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: Data From the global non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) registry

• Main Authors: Younossi, Zobair M., Yilmaz, Yusuf, Yu, Ming-Lung, Wong, Vincent Wai-Sun, Fernandez, Marlen Castellanos, Isakov, Vasily A., Duseja, Ajay K., Mendez-Sanchez, Nahum, Eguchi, Yuichiro, Bugianesi, Elisabetta, Burra, Patrizia, George, Jacob, Fan, Jian-Gao, Papatheodoridis, George, Chan, Wah Kheong, Alswat, Khalid, Saeed, Hamid S., Singal, Ashwani K., Romero-Gomez, Manuel, Gordon, Stuart C., Roberts, Stuart K., El Kassas, Mohamed, Kugelmas, Marcelo, Ong, Janus P., Alqahtani, Saleh, Ziayee, Mariam, Lam, Brian, Younossi, Issah, Racila, Andrei, Henry, Linda, Stepanova, Maria, Council, Global Nash
• Format: Article
• Published: Elsevier 2022
• Subjects: R Medicine (General)
• Online Access: http://eprints.um.edu.my/40410/; https://doi.org/10.1016/j.cgh.2021.11.004

BACKGROUND & AIMS: Globally, nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. We assessed the clinical presentation and patient-reported outcomes (PROs) among NAFLD patients from different countries. METHODS: Clinical, laboratory, and PRO data (Chronic Liver D...